BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27318478)

  • 1. Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
    Tian Y; Yang Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Lu Y; Moriya K; Koike K; Gonzalez FJ; Aoyama T
    Glycoconj J; 2016 Dec; 33(6):927-936. PubMed ID: 27318478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
    Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
    J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
    Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T
    Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PPARα by Fatty Acid Accumulation Enhances Fatty Acid Degradation and Sulfatide Synthesis.
    Yang Y; Feng Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Aoyama T
    Tohoku J Exp Med; 2016 Oct; 240(2):113-22. PubMed ID: 27644403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
    Zhang X; Nakajima T; Kamijo Y; Li G; Hu R; Kannagi R; Kyogashima M; Aoyama T; Hara A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1382-8. PubMed ID: 19895791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.
    Nakajima T; Kamijo Y; Yuzhe H; Kimura T; Tanaka N; Sugiyama E; Nakamura K; Kyogashima M; Hara A; Aoyama T
    Glycoconj J; 2013 Aug; 30(6):553-60. PubMed ID: 23065187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
    Sun HY; Lin CC; Tsai PJ; Tsai WJ; Lee JC; Tsao CW; Cheng PN; Wu IC; Chiu YC; Chang TT; Young KC
    Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis].
    Tanaka N; Aoyama T
    Nihon Rinsho; 2004 Nov; 62(11):2137-44. PubMed ID: 15552900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor α attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice.
    Lu Y; Harada M; Kamijo Y; Nakajima T; Tanaka N; Sugiyama E; Kyogashima M; Gonzalez FJ; Aoyama T
    Arch Toxicol; 2019 Jan; 93(1):149-161. PubMed ID: 30341732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice.
    Kimura T; Nakajima T; Kamijo Y; Tanaka N; Wang L; Hara A; Sugiyama E; Tanaka E; Gonzalez FJ; Aoyama T
    PPAR Res; 2012; 2012():174932. PubMed ID: 22645601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Sulfatides Physiological Function and Peroxisome Proliferator-Activated Receptor α.
    Li TT; Li G; Hu R; Ji X; Liu C; Shao YT
    Neurochem Res; 2023 Jul; 48(7):2059-2065. PubMed ID: 36879104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypertension and antihypertensive treatments on sulfatide levels in serum and its metabolism.
    Guo R; Hu X; Yamada Y; Harada M; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
    Hypertens Res; 2019 May; 42(5):598-609. PubMed ID: 30531843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis.
    Yang Q; Ito S; Gonzalez FJ
    Carcinogenesis; 2007 Jun; 28(6):1171-7. PubMed ID: 17331954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
    Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC
    Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress.
    Sheng X; Nakajima T; Wang L; Zhang X; Kamijo Y; Takahashi K; Tanaka N; Sugiyama E; Kyogashima M; Aoyama T; Hara A
    Tohoku J Exp Med; 2012 May; 227(1):1-12. PubMed ID: 22499158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
    Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
    Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
    Dharancy S; Malapel M; Perlemuter G; Roskams T; Cheng Y; Dubuquoy L; Podevin P; Conti F; Canva V; Philippe D; Gambiez L; Mathurin P; Paris JC; Schoonjans K; Calmus Y; Pol S; Auwerx J; Desreumaux P
    Gastroenterology; 2005 Feb; 128(2):334-42. PubMed ID: 15685545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
    van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
    J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.
    Nguyen T; Xu J; Chikuma S; Hiai H; Kinoshita K; Moriya K; Koike K; Marcuzzi GP; Pfister H; Honjo T; Kobayashi M
    Int Immunol; 2014 Jul; 26(7):397-406. PubMed ID: 24569264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.